Men and women often face different hurdles when it comes to getting screened for colorectal cancer. These differences can affect how often they get tested, the age at which they develop cancer, and the specific types of growths they develop. Because of these differences, a one-size-fits-all approach to screening might not be the most effective way to reach everyone.
Experts recently met to discuss how to make screening programs fairer and more effective. They found that we need to collect and look at data specifically separated by sex and gender. By doing this, doctors can better understand the unique barriers each group faces. This helps them create communication strategies that speak directly to the concerns of both men and women.
While the experts agreed on the need for more tailored communication and research, they also noted that there are still gaps in our current knowledge. Because this was a consensus based on existing literature and expert discussion rather than a new clinical trial, more research is needed to find the best screening methods for everyone.
Common questions
Why is it important to have different screening strategies for men and women?
Men and women show significant differences in colorectal cancer, including the age they are diagnosed and the types of lesions they develop. They also face different barriers to getting screened. Tailoring communication and screening methods to these specific differences helps make programs more effective and fair for everyone.
What are the main goals of these new recommendations?
The goal is to improve equity and effectiveness in screening programs. Experts recommend collecting sex-disaggregated data and creating communication strategies that address gender-specific barriers. This helps ensure that both men and women have the best chance at early detection and treatment.
Is this new approach based on a clinical trial?
No, these findings come from a consensus study based on a literature review and expert panel discussions. While the experts agree on the importance of tailored screening, they noted that there are still gaps in our current knowledge regarding sex and gender differences in colorectal cancer.
